Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ben-Shahar

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
The American Journal of Pediatric Hematology/Oncology|May 1, 1994
Hodgkin's disease in childhood: treatment modalities, outcome and epidemiological aspects. The Northern Israel Cancer Center experienceJ Rosenthal, M W Ben Arush, A Kuten, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1995
Full dose CHOP chemotherapy in elderly patients with non-Hodgkin's lymphomaR Epelbaum, N Haim, M Leviov, et al.
Psychopharmacology|February 26, 2009
Anxiolytic effects of nicotine in a rodent test of approach-avoidance conflictAmi Cohen, Robert W Young, Miguel A Velazquez, et al.
Cancer|September 15, 1990
Survival of diffuse large cell lymphoma. A multivariate analysis including dose intensity variablesR Epelbaum, D Faraggi, Y Ben-Arie, et al.
Bone Marrow Transplantation|November 1, 1989
Severe giardiasis in two patients undergoing bone marrow transplantationR Bromiker, S H Korman, R Or, et al.
International Journal of Radiation Oncology, Biology, Physics|September 30, 1993
The management of metastatic spinal cord compression: a radiotherapeutic success ceilingM Leviov, J Dale, M Stein, et al.
Pathology Oncology Research : POR|January 15, 1999
Haptoglobin-related protein as a serum marker in malignant lymphomaR Epelbaum, C Shalitin, R Segal, et al.
Harefuah|April 17, 2001
[The chemotherapeutic treatment of advanced Hodgkin's disease]R Epelbaum, N Haim, M Ben-Shahar, et al.
Blood|October 1, 1992
Enhanced marrow recovery by short preincubation of marrow allografts with human recombinant interleukin-3 and granulocyte-macrophage colony-stimulating factorE Naparstek, Y Hardan, M Ben-Shahar, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Immunological evaluation of patients with hematological malignancies receiving ambulatory cytokine-mediated immunotherapy with recombinant human interferon-alpha 2a and interleukin-2S Morecki, S Revel-Vilk, C Nabet, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
The American Journal of Pediatric Hematology/Oncology|May 1, 1994
Hodgkin's disease in childhood: treatment modalities, outcome and epidemiological aspects. The Northern Israel Cancer Center experienceJ Rosenthal, M W Ben Arush, A Kuten, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1995
Full dose CHOP chemotherapy in elderly patients with non-Hodgkin's lymphomaR Epelbaum, N Haim, M Leviov, et al.
Psychopharmacology|February 26, 2009
Anxiolytic effects of nicotine in a rodent test of approach-avoidance conflictAmi Cohen, Robert W Young, Miguel A Velazquez, et al.
Cancer|September 15, 1990
Survival of diffuse large cell lymphoma. A multivariate analysis including dose intensity variablesR Epelbaum, D Faraggi, Y Ben-Arie, et al.
Bone Marrow Transplantation|November 1, 1989
Severe giardiasis in two patients undergoing bone marrow transplantationR Bromiker, S H Korman, R Or, et al.
International Journal of Radiation Oncology, Biology, Physics|September 30, 1993
The management of metastatic spinal cord compression: a radiotherapeutic success ceilingM Leviov, J Dale, M Stein, et al.
Pathology Oncology Research : POR|January 15, 1999
Haptoglobin-related protein as a serum marker in malignant lymphomaR Epelbaum, C Shalitin, R Segal, et al.
Harefuah|April 17, 2001
[The chemotherapeutic treatment of advanced Hodgkin's disease]R Epelbaum, N Haim, M Ben-Shahar, et al.
Blood|October 1, 1992
Enhanced marrow recovery by short preincubation of marrow allografts with human recombinant interleukin-3 and granulocyte-macrophage colony-stimulating factorE Naparstek, Y Hardan, M Ben-Shahar, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Immunological evaluation of patients with hematological malignancies receiving ambulatory cytokine-mediated immunotherapy with recombinant human interferon-alpha 2a and interleukin-2S Morecki, S Revel-Vilk, C Nabet, et al.
Pageof 4